Literature DB >> 27873247

Computer-Aided Drug Design Methods.

Wenbo Yu1, Alexander D MacKerell2.   

Abstract

Computational approaches are useful tools to interpret and guide experiments to expedite the antibiotic drug design process. Structure-based drug design (SBDD) and ligand-based drug design (LBDD) are the two general types of computer-aided drug design (CADD) approaches in existence. SBDD methods analyze macromolecular target 3-dimensional structural information, typically of proteins or RNA, to identify key sites and interactions that are important for their respective biological functions. Such information can then be utilized to design antibiotic drugs that can compete with essential interactions involving the target and thus interrupt the biological pathways essential for survival of the microorganism(s). LBDD methods focus on known antibiotic ligands for a target to establish a relationship between their physiochemical properties and antibiotic activities, referred to as a structure-activity relationship (SAR), information that can be used for optimization of known drugs or guide the design of new drugs with improved activity. In this chapter, standard CADD protocols for both SBDD and LBDD will be presented with a special focus on methodologies and targets routinely studied in our laboratory for antibiotic drug discoveries.

Entities:  

Keywords:  Computer-aided drug design; Docking; Force field; Molecular dynamics; Pharmacophore; SILCS; Site identification by ligand competitive saturation; Structure-activity relationship; Virtual screening

Mesh:

Substances:

Year:  2017        PMID: 27873247      PMCID: PMC5248982          DOI: 10.1007/978-1-4939-6634-9_5

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  89 in total

Review 1.  Computer-based de novo design of drug-like molecules.

Authors:  Gisbert Schneider; Uli Fechner
Journal:  Nat Rev Drug Discov       Date:  2005-08       Impact factor: 84.694

2.  Automatic atom type and bond type perception in molecular mechanical calculations.

Authors:  Junmei Wang; Wei Wang; Peter A Kollman; David A Case
Journal:  J Mol Graph Model       Date:  2006-02-03       Impact factor: 2.518

Review 3.  Computational identification of inhibitors of protein-protein interactions.

Authors:  Shijun Zhong; Alba T Macias; Alexander D MacKerell
Journal:  Curr Top Med Chem       Date:  2007       Impact factor: 3.295

4.  Binding response: a descriptor for selecting ligand binding site on protein surfaces.

Authors:  Shijun Zhong; Alexander D MacKerell
Journal:  J Chem Inf Model       Date:  2007-09-27       Impact factor: 4.956

5.  New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays.

Authors:  Jonathan B Baell; Georgina A Holloway
Journal:  J Med Chem       Date:  2010-04-08       Impact factor: 7.446

6.  Automation of the CHARMM General Force Field (CGenFF) II: assignment of bonded parameters and partial atomic charges.

Authors:  K Vanommeslaeghe; E Prabhu Raman; A D MacKerell
Journal:  J Chem Inf Model       Date:  2012-11-28       Impact factor: 4.956

7.  Constant pH molecular dynamics with proton tautomerism.

Authors:  Jana Khandogin; Charles L Brooks
Journal:  Biophys J       Date:  2005-04-29       Impact factor: 4.033

8.  Optimization of the additive CHARMM all-atom protein force field targeting improved sampling of the backbone φ, ψ and side-chain χ(1) and χ(2) dihedral angles.

Authors:  Robert B Best; Xiao Zhu; Jihyun Shim; Pedro E M Lopes; Jeetain Mittal; Michael Feig; Alexander D Mackerell
Journal:  J Chem Theory Comput       Date:  2012-07-18       Impact factor: 6.006

Review 9.  Molecular mechanics.

Authors:  Kenno Vanommeslaeghe; Olgun Guvench; Alexander D MacKerell
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

10.  Turning defense into offense: defensin mimetics as novel antibiotics targeting lipid II.

Authors:  Kristen M Varney; Alexandre M J J Bonvin; Marzena Pazgier; Jakob Malin; Wenbo Yu; Eugene Ateh; Taiji Oashi; Wuyuan Lu; Jing Huang; Marlies Diepeveen-de Buin; Joseph Bryant; Eefjan Breukink; Alexander D Mackerell; Erik P H de Leeuw
Journal:  PLoS Pathog       Date:  2013-11-07       Impact factor: 6.823

View more
  42 in total

1.  Ranking Reversible Covalent Drugs: From Free Energy Perturbation to Fragment Docking.

Authors:  Han Zhang; Wenjuan Jiang; Payal Chatterjee; Yun Luo
Journal:  J Chem Inf Model       Date:  2019-02-27       Impact factor: 4.956

2.  A computationally affordable approach for accurate prediction of the binding affinity of JAK2 inhibitors.

Authors:  Nguyen Thi Mai; Ngo Thi Lan; Thien Y Vu; Nguyen Thanh Tung; Huong Thi Thu Phung
Journal:  J Mol Model       Date:  2022-05-23       Impact factor: 1.810

3.  On the force field optimisation of [Formula: see text]-lactam cores using the force field Toolkit.

Authors:  Qiyang Wu; Tianyang Huang; Songyan Xia; Frank Otto; Tzong-Yi Lee; Hsien-Da Huang; Ying-Chih Chiang
Journal:  J Comput Aided Mol Des       Date:  2022-07-11       Impact factor: 4.179

4.  Computational exploration of maternal embryonic leucine zipper kinase (MELK) as a cancer drug target.

Authors:  Nahlah Makki Almansour
Journal:  Saudi J Biol Sci       Date:  2022-06-01       Impact factor: 4.052

Review 5.  Rethinking drug design in the artificial intelligence era.

Authors:  Petra Schneider; W Patrick Walters; Alleyn T Plowright; Norman Sieroka; Jennifer Listgarten; Robert A Goodnow; Jasmin Fisher; Johanna M Jansen; José S Duca; Thomas S Rush; Matthias Zentgraf; John Edward Hill; Elizabeth Krutoholow; Matthias Kohler; Jeff Blaney; Kimito Funatsu; Chris Luebkemann; Gisbert Schneider
Journal:  Nat Rev Drug Discov       Date:  2019-12-04       Impact factor: 84.694

6.  Fullerene Derivatives as Lung Cancer Cell Inhibitors: Investigation of Potential Descriptors Using QSAR Approaches.

Authors:  Hung-Jin Huang; Olga A Kraevaya; Ilya I Voronov; Pavel A Troshin; Shan-Hui Hsu
Journal:  Int J Nanomedicine       Date:  2020-04-14

Review 7.  Residue-based pharmacophore approaches to study protein-protein interactions.

Authors:  Rojan Shrestha; Jorge Eduardo Fajardo; Andras Fiser
Journal:  Curr Opin Struct Biol       Date:  2021-01-22       Impact factor: 6.809

8.  Current Trends in GPCR Allostery.

Authors:  Khuraijam Dhanachandra Singh; Sadashiva S Karnik
Journal:  J Membr Biol       Date:  2021-01-20       Impact factor: 1.843

Review 9.  Artificial Intelligence and the Future of Diagnostic and Therapeutic Radiopharmaceutical Development:: In Silico Smart Molecular Design.

Authors:  Bahar Ataeinia; Pedram Heidari
Journal:  PET Clin       Date:  2021-08-05

10.  In Silico Approach Using Free Software to Optimize the Antiproliferative Activity and Predict the Potential Mechanism of Action of Pyrrolizine-Based Schiff Bases.

Authors:  Faisal A Almalki; Ashraf N Abdalla; Ahmed M Shawky; Mahmoud A El Hassab; Ahmed M Gouda
Journal:  Molecules       Date:  2021-06-30       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.